Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.
about
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus.
P2860
Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@en
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@nl
type
label
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@en
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@nl
prefLabel
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@en
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
Relative Bioavailability of a ...... oinjector in Healthy Subjects.
@en
P2093
David Gordon
David Roth
Herbert Struemper
James Groark
Jane Gilbert
Joseph Fire
Matthew E Barton
Norma Lynn Fox
Thomas Murtaugh
P2860
P304
P356
10.1002/CPDD.219
P577
2015-12-04T00:00:00Z